|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 768.58 USD | +1.04% |
|
+10.56% | -0.43% |
| Market Cap | 75.96B 65.75B 61.26B 56.43B 106B 7,224B 108B 720B 283B 3,613B 285B 279B 11,979B | P/E 2026 * |
18x | P/E 2027 * | 15.1x |
|---|---|---|---|---|---|
| Enterprise Value | 69.09B 59.8B 55.72B 51.33B 96.79B 6,571B 97.96B 655B 257B 3,286B 259B 254B 10,896B | EV / Sales 2026 * |
4.09x | EV / Sales 2027 * | 3.57x |
| Free-Float |
71.07% | Yield 2026 * |
0.51% | Yield 2027 * | 0.58% |
Last Transcript: Regeneron Pharmaceuticals, Inc.
| 1 day | +1.04% | ||
| 1 week | +10.56% | ||
| Current month | +0.78% | ||
| 1 month | +17.47% | ||
| 3 months | +8.37% | ||
| 6 months | -0.84% | ||
| Current year | -0.43% |
| 1 week | 694.98 |  | 782.59 |
| 1 month | 637.72 | | 782.59 |
| Current year | 591.52 | | 821.11 |
| 1 year | 541 | | 821.11 |
| 3 years | 476.49 | | 1,211.2 |
| 5 years | 476.49 | | 1,211.2 |
| 10 years | 271.37 | | 1,211.2 |
| Manager | Title | Age | Since |
|---|---|---|---|
| President | 66 | 2000-12-31 | |
| Chief Executive Officer | 73 | 1988-01-07 | |
| Director of Finance/CFO | 55 | 2024-02-04 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 73 | 2023-06-08 | |
Michael Brown
BRD | Director/Board Member | 85 | 1991-05-31 |
Joseph Goldstein
BRD | Director/Board Member | 85 | 1991-05-31 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 7/2/26 | Sell | Director | -200 | 0.0002% | ||
| 2/19/26 | Fiscal year | Director | 4,914 | 0.0048% | ||
| 2/9/26 | Fiscal year | SVP Controller | 4,036 | 0.0039% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.04% | +10.56% | +34.48% | +0.28% | 75.96B | |
| +2.64% | -8.39% | +24.13% | +188.08% | 49.03B | |
| +1.02% | -3.74% | -7.47% | +21.83% | 47.88B | |
| +1.42% | +9.32% | -50.68% | -50.72% | 43.39B | |
| -0.87% | +0.50% | +56.30% | -23.16% | 30.8B | |
| -0.66% | -7.80% | +53.51% | +88.28% | 24.45B | |
| -1.29% | +0.81% | +103.53% | -48.00% | 22.75B | |
| +4.15% | +0.44% | -2.80% | +175.30% | 19.24B | |
| -0.10% | -4.16% | +71.71% | +162.37% | 16.04B | |
| +1.05% | -5.57% | +63.38% | +118.00% | 15.87B | |
| Average | +0.84% | -1.38% | +34.61% | +63.23% | 34.54B | |
| Weighted average by Cap. | +0.99% | +0.26% | +25.32% | +47.17% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 16.89B 14.62B 13.62B 12.55B 23.66B 1,606B 23.95B 160B 62.85B 803B 63.43B 62.03B 2,663B | 18.34B 15.88B 14.79B 13.62B 25.7B 1,744B 26.01B 174B 68.25B 872B 68.88B 67.36B 2,892B |
| Net income | 4.61B 3.99B 3.72B 3.42B 6.45B 438B 6.53B 43.68B 17.14B 219B 17.3B 16.92B 726B | 5.35B 4.63B 4.32B 3.98B 7.5B 509B 7.59B 50.75B 19.92B 255B 20.1B 19.66B 844B |
| Net Debt | -6.87B -5.95B -5.54B -5.1B -9.62B -653B -9.74B -65.12B -25.56B -327B -25.79B -25.23B -1,083B | -10.55B -9.14B -8.51B -7.84B -14.79B -1,004B -14.96B -100B -39.28B -502B -39.63B -38.76B -1,664B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-08-05 | $768.58 | +1.04% | 529,970 |
| 26-08-04 | $760.66 | +0.19% | 817,280 |
| 26-08-03 | $759.24 | -0.44% | 842,730 |
| 26-07-31 | $762.63 | +3.29% | 1,158,583 |
| 26-07-30 | $738.34 | +6.17% | 1,460,963 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- REGN Stock
Select your edition
All financial news and data tailored to specific country editions
